Key result
Lycopene lowers blood pressure and improves lipids and inflammatory markers in CV risk patients.
Why the study?
Effective prevention and management strategies for cardiovascular disease are needed, and the impact of lycopene on cardiovascular health requires systematic evaluation.
Does lycopene improve blood pressure, lipid profiles, and oxidative stress in participants with cardiovascular risk factors?
Systematic Review (n=385)
Does lycopene improve blood pressure, lipid profiles, and oxidative stress in participants with cardiovascular risk factors?
Lycopene supplementation shows potential for improving cardiovascular risk factors, including blood pressure and lipid profiles, though optimal dosing requires further study.
Supports lycopene supplementation in CV risk patients; extends Level 1 evidence while leaving optimal dosing unresolved.
Cardiovascular disease remains a leading global cause of mortality, demanding effective prevention and management. This systematic review explores the impact of lycopene, prevalent in various fruits, on cardiovascular health. Thirteen randomized and controlled trials were analyzed, involving 385 participants with cardiovascular risk factors. Notable findings included significant blood pressure reductions, particularly among hypertensive individuals, and favorable alterations in lipid profiles. Lycopene interventions also demonstrated potential in mitigating oxidative stress and inflammation markers. While these findings show promise, more rigorously designed studies are essential to determine optimal dosages and durations for precise cardiovascular benefits. In conclusion, lycopene shows potential in managing cardiovascular risk factors, and its role in blood pressure regulation, lipid profile improvement, and antioxidant and anti-inflammatory effects is encouraging. Nonetheless, further research is warranted to provide definitive guidance on integrating lycopene to enhance cardiovascular health.
No takes yet. Share an insight, caveat, or question.
Joung et al. (2023) conducted a systematic review in Cardiovascular risk factors (n=385). Lycopene was evaluated on Blood pressure, lipid profiles, oxidative stress, and inflammation markers. Lycopene interventions significantly reduced blood pressure and favorably altered lipid profiles, oxidative stress, and inflammation markers in participants with cardiovascular risk factors.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: